BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Despite toxicity concerns for CD47 targets in 2023\, the macro
 phage therapies space remains determined to drive revolutionary treatment
 s for oncology\, autoimmunity\, inflammation\, neurodegenerative disorder
 s\, and beyond. From pioneering the next generation of CAR-M therapies to
  unveiling novel targets\, this field is on a mission to learn from the p
 ast and spearhead pipelines into clinical development.\n\nWith that\, the
  6th Macrophage-Directed Therapies Summit will return to Boston this year
 \, uniting 60+ biopharma and academia leaders across R and D\, Discovery\
 , Biology\, Translational\, and Clinical Development fields. As a uniquel
 y positioned platform\, this event is perfect for those committed to reig
 niting excitement in macrophage pipeline advancement.\n\nThis is your cha
 nce to gain exclusive insights from industry giants like Verseau Therapeu
 tics\, Inceptor Bio\, Resolution Therapeutics\, and Elpisicence Biopharma
 ceuticals\, as they unravel macrophage biology and accelerate towards pro
 of-of-concept data.\n\nDownload the Full Agenda - https://ter.li/ywwpo1\n
 \nRegister Now - https://ter.li/6sva6d\n\nDate and Time: Tuesday\, 01 Oct
 ober 2024 at 07:30 to Thursday\, 03 October 2024 at 17:45\n
DTEND:20241003T174500
DTSTAMP:20260512T231934Z
DTSTART:20241001T073000
LOCATION:Hilton Boston Back Bay\, 40 Dalton Street\, Boston\, Massachusett
 s\, 02115\,
SEQUENCE:0
SUMMARY:Despite toxicity concerns for CD47 targets in 2023\, the macrophag
 e therapies space remains determined to drive revolutionary treatments fo
 r oncolog...
UID:bdfb0720-e01f-4aee-be22-06eb7e2a2178
END:VEVENT
END:VCALENDAR